Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
Breast Cancer, Hot Flashes
About this trial
This is an interventional supportive care trial for Breast Cancer focused on measuring breast cancer, hot flashes
Eligibility Criteria
DISEASE CHARACTERISTICS: History of breast cancer OR a concern about taking hormonal therapy due to a fear of developing breast cancer Experiencing bothersome hot flashes, defined as patient-reported occurrence ≥ 14 times per week AND sufficiently severe to prompt desire for additional therapeutic intervention despite current use of an antidepressant Currently (≥ 2 weeks) being treated with a stable dose of an antidepressant No monoamine oxidase inhibitors or tricyclics No current evidence of malignant disease Hormone receptor status: Not specified PATIENT CHARACTERISTICS: Age 18 and over Sex Female Performance status ECOG 0-1 Life expectancy At least 6 months Other Not pregnant or nursing Negative pregnancy test Fertile patients must use effective barrier contraception PRIOR CONCURRENT THERAPY: Chemotherapy More than 4 weeks since prior antineoplastic chemotherapy No concurrent antineoplastic chemotherapy Endocrine therapy More than 4 weeks since prior androgens, estrogens, or progestational agents More than 2 weeks since prior dehydroepiandrosterone (DHEA) for treatment of hot flashes No concurrent androgens, estrogens, or progestational agents, including oral contraceptives No concurrent DHEA for treatment of hot flashes Concurrent tamoxifen, raloxifene, or aromatase inhibitor therapy allowed if on a stable dose for at least 4 weeks prior to study entry and during study treatment Other No prior gabapentin More than 2 weeks since other prior treatment for hot flashes (e.g., clonidine or Bellergal-S®) Concurrent vitamin E or soy supplements allowed if on a stable dose for at least 1 month prior to study entry and during study treatment No other concurrent treatment for hot flashes (e.g., clonidine or Bellergal-S®) No other concurrent antidepressants
Sites / Locations
- CCOP - Mayo Clinic Scottsdale Oncology Program
- Mayo Clinic - Jacksonville
- MBCCOP-Medical College of Georgia Cancer Center
- Rush-Copley Cancer Care Center
- St. Joseph Medical Center
- Graham Hospital
- Memorial Hospital
- Eureka Hospital
- Galesburg Clinic
- Galesburg Cottage Hospital
- InterCommunity Cancer Center of Western Illinois
- Mason District Hospital
- Hopedale Medical Complex
- Joliet Oncology Hematology Associates, Limited - West
- Kewanee Hospital
- McDonough District Hospital
- Trinity Medical Center - East
- BroMenn Regional Medical Center
- Community Cancer Center
- Community Hospital of Ottawa
- Oncology Hematology Associates of Central Illinois - Ottawa
- Cancer Treatment Center at Pekin Hospital
- Methodist Medical Center of Illinois
- Proctor Hospital
- CCOP - Illinois Oncology Research Association
- Oncology/Hematology Associates of Central Illinois, P.C.
- OSF St. Francis Medical Center
- Illinois Valley Community Hospital
- Perry Memorial Hospital
- St. Margaret's Hospital
- Valley Cancer Center
- Carle Cancer Center at Carle Foundation Hospital
- CCOP - Carle Cancer Center
- St. Francis Hospital and Health Centers
- Saint Anthony Memorial Health Centers
- McFarland Clinic, P.C.
- Saint Anthony Regional Hospital
- St. Luke's Hospital
- Cedar Rapids Oncology Associates
- Mercy Cancer Center at Mercy Medical Center
- Alegent Health Mercy Hospital
- Mercy Capitol Hospital
- CCOP - Iowa Oncology Research Association
- John Stoddard Cancer Center at Iowa Methodist Medical Center
- Medical Oncology and Hematology Associates at John Stoddard Cancer Center
- Medical Oncology and Hematology Associates at Mercy Cancer Center
- Mercy Cancer Center at Mercy Medical Center - Des Moines
- John Stoddard Cancer Center at Iowa Lutheran Hospital
- Mercy Cancer Center at Mercy Medical Center - North Iowa
- Alegent Health Community Memorial Hospital
- Burgess Health Center
- Cancer Center at Ottumwa Regional Health Center
- Siouxland Regional Cancer Center
- Siouxland Hematology-Oncology Associates
- Mercy Medical Center - Sioux City
- St. Luke's Regional Medical Center
- Medical Oncology and Hematology Associates - West Des Moines
- Cancer Center of Kansas - Chanute
- Cancer Center of Kansas - Dodge City
- Cancer Center of Kansas, P.A. - El Dorado
- Cancer Center of Kansas - Kingman
- Southwest Medical Center
- Cancer Center of Kansas - Newton
- Cancer Center of Kansas, P.A. - Parsons
- Pratt Cancer Center of Kansas
- Cancer Center of Kansas - Salina
- Cancer Center of Kansas - Wellington
- Associates in Womens Health
- Cancer Center of Kansas, P.A.
- Cancer Center of Kansas, P.A. - Wichita
- CCOP - Wichita
- Via Christi Cancer Center at Via Christi Regional Medical Center
- Cancer Center of Kansas - Winfield
- CCOP - Michigan Cancer Research Consortium
- St. Joseph Mercy Cancer Center at St. Joseph Mercy Hospital
- Green Bay Oncology, Limited - Escanaba
- Genesys Hurley Cancer Institute
- Green Bay Oncology, Limited - Iron Mountain
- Sparrow Regional Cancer Center
- Seton Cancer Institute - Saginaw
- St. John Macomb Hospital
- MeritCare Clinic - Bemidji
- Brainerd Medical Center
- St. Joseph's Medical Center
- Fairview Ridges Hospital
- Mercy Hospital
- Fairview Southdale Hospital
- Mercy and Unity Cancer Center at Mercy and Unity Hospitals
- Hutchinson Area Health Care
- Meeker County Memorial Hospital
- St. John's Hospital
- Virginia Piper Cancer Institute at Abbott-Northwestern Hospital
- Hennepin County Medical Center - Minneapolis
- Chippewa County - Montevideo Hospital
- Hubert H. Humphrey Cancer Center at North Memorial Medical Center
- Mayo Clinic Cancer Center
- St. Cloud Hospital
- CCOP - Metro-Minnesota
- Cancer Care Center at Regions Hospital
- Saint Francis Cancer Center
- St. Joseph's Hospital
- Adult and Pediatric Urology, P.L.L.P.
- CentraCare Clinic - River Campus
- Park Nicollet Clinic
- United Hospital
- Ridgeview Medical Center
- Woodwinds Hospital
- CCOP - Montana Cancer Consortium
- Deaconess Billings Clinic - Downtown
- Northern Rockies Radiation Oncology Center
- St. Vincent Healthcare
- Deaconess Billings Clinic Cancer Center
- Bozeman Deaconess Hospital
- St. James Community Hospital
- Great Falls Clinic
- Sletten Regional Cancer Institute
- St. Peter's Hospital
- Kalispell Regional Medical Center
- Eastern Montana Cancer Center
- Community Medical Center
- Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
- Fremont Area Medical Center
- Bryan LGH Medical Center West
- Cancer Resource Center - Lincoln
- St. Elizabeth Regional Medical Center
- CCOP - Missouri Valley Cancer Consortium
- Immanuel Medical Center
- Bergan Mercy Medical Center
- Cancer Center at Creighton University Medical Center
- Midlands Cancer Center at Midlands Community Hospital
- Rutherford Hospital
- Bismarck Cancer Center
- Medcenter One Health System
- Mid Dakota Clinic, P.C.
- St. Alexius Medical Center
- CCOP - MeritCare Hospital
- MeritCare Medical Group
- Grandview Hospital
- Good Samaritan Hospital
- Samaritan North Cancer Care Center
- Veterans Affairs Medical Center - Dayton
- CCOP - Dayton
- Charles F. Kettering Memorial Hospital
- Middletown Regional Hospital
- UVMC Cancer Care Center at Upper Valley Medical Center
- United States Air Force Medical Center Wright-Patterson
- Ruth G. McMillan Cancer Center at Greene Memorial Hospital
- John and Dorothy Morgan Cancer Center at Lehigh Valley Hospital
- Guthrie Medical Center - Sayre
- Rose Ramer Cancer Clinic at Anderson Area Medical Center
- Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
- CCOP - Upstate Carolina
- Sioux Valley Hospital and University of South Dakota Medical Center
- Avera McKennan Hospital and University Health Center
- Medical X-Ray Center
- Green Bay Oncology, Limited at St. Vincent Hospital
- St. Vincent Hospital
- Green Bay Oncology, Limited at St. Mary's Hospital
- St. Mary's Hospital Medical Center
- Green Bay Oncology, Limited - Oconto Falls
- Green Bay Oncology, Limited - Sturgeon Bay
- Welch Cancer Center
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
gabapentin + antidepressant
gabapentin
Patients continue to receive the same antidepressant (as before study entry) on weeks 1-5. During weeks 2-5, patients also receive oral gabapentin once daily on days 8-10, twice daily on days 11-13, and then three times daily on days 14-35 in the absence of unacceptable toxicity. Patients complete a hot flash diary at baseline and then daily during study treatment.
Patients receive gabapentin once daily on days 8-10, twice daily on days 11-13, and then three times daily on days 14-35 in the absence of unacceptable toxicity. Patients are tapered off their antidepressant over 7-10 days and remain on gabapentin alone. Patients complete a hot flash diary at baseline and then daily during study treatment.